KK

Keshava Kammaralli Suraiah Murthy

Director Nominee Director DIN 00202383
DIN 00202383 First appointment Dec 2002 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2002
Shareholding value •••• Premium profile

About Keshava Kammaralli Suraiah Murthy

Data last updated:

Keshava Kammaralli Suraiah Murthy was a Nominee Director at Srini Pharmaceuticals Private Limited (2002–2009) and Director at Apotex Pharmachem India Private Limited (2004–2009). The companies operate in Pharma.

DIN 00202383
Primary Designation Nominee Director
Industry Pharma
First Appointment 30 Dec 2002

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nominee Director30 Dec 20021995₹166 Cr (FY 2024)Active
Director24 Jun 20042003₹142 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Srini Pharmaceuticals Private Limited
Apotex Pharmachem India Private Limited
Premium access

Shareholding and investment profile for Keshava Kammaralli Suraiah Murthy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Keshava Kammaralli Suraiah Murthy

Keshava Kammaralli Suraiah Murthy was first appointed on 30 Dec 2002 as Nominee Director at Srini Pharmaceuticals Private Limited. The most recent appointment on record is 24 Jun 2004 at Apotex Pharmachem India Private Limited.

Keshava Kammaralli Suraiah Murthy held 2 earlier board appointments: Srini Pharmaceuticals Private Limited (Nominee Director, 30 Dec 2002 to 26 Oct 2009); Apotex Pharmachem India Private Limited (Director, 24 Jun 2004 to 26 Oct 2009).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available